Page last updated: 2024-11-01

nifedipine and Esophageal Squamous Cell Carcinoma

nifedipine has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"A cohort of 566 patients with achalasia (46% men, mean age at diagnosis: 48."1.62Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy. ( Bazzoli, F; Ferretti, S; Fortunato, F; Lugaresi, M; Marasco, G; Mattioli, S; Tassi, V; Zagari, RM, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zagari, RM1
Marasco, G1
Tassi, V1
Ferretti, S1
Lugaresi, M1
Fortunato, F1
Bazzoli, F1
Mattioli, S1

Other Studies

1 other study available for nifedipine and Esophageal Squamous Cell Carcinoma

ArticleYear
Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy.
    The American journal of gastroenterology, 2021, 02-01, Volume: 116, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Calcium Channel Blockers; Cohort Studies; Dilatation; Esophageal Achala

2021